Please assess the completion status of the following clinical trial:

Trial Title: Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Have Type 2 diabetes mellitus.~* Have a Body Mass Index within range 22 to 35kg/m2 inclusive.~* Females who meet above criteria must be physiologically incapable of becoming pregnant (i.e., surgically sterilized, or post-menopausal per protocol definition).~Exclusion criteria:~* Are currently taking insulin therapy.~* Have any disease (such as heart, liver, blood, nervous system, or kidney disease, or cancer).~* Have a history of stomach, liver, kidney, or other disease that with interfere with taking the study drug.~* Are currently using diuretics, oral or injectable corticosteroids (inhaled \& intranasal corticosteroids are permitted), or other medications that would cause you to deplete your fluid balance in your body; currently taking stable regimens for heart conditions; currently using prescription or non-prescription drugs within 7 days of starting the study that may interfere with the study drug.~* Would donate more than 450 ML of blood over a 2 month period.~* Physician does not think it is a good idea for you to participate in the trial. - Had a urinary tract infection or bladder infection in the last month. - Are currently drinking more than 2 beers, 1 glass of wine, or 1 glass of spirits daily.~* Have a positive urine drug screen test.~* Plan to change your smoking habits during the course of the trial.~* Have Hepatitis C, Hepatitis B, or HIV. - Have a lab or EKG abnormality. - High or low blood pressure.~* Have used of any investigational drug or device during the study or within 30 days prior to 1st dosing of study medication.~* Are a male subject unwilling to abstain or use protection during intercourse.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).